Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
Clinical trial NCT01362374 · COMPLETED
Trial details
- NCT number
- NCT01362374
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-11
- Primary completion
- 2020-10-16
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.